Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid

Journal of the National Cancer Institute

Volumn 93, Issue 23, 2001, Pages 1791-1798

  Wrensch, Margaret R ^a   Petrakis, Nicholas L ^a   Miike, Rei ^a   King, Eileen B ^a   Chew, Karen ^b   Neuhaus, John ^a   Lee, Marion M ^a   Rhys, Moore ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CANCER STATISTICS; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NIPPLE; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNITED STATES;

EID: 0035814436     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.23.1791     Document Type: Article

References (65)

1. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid
2. Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy
3. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells
4. Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings
5. Breast secretory activity in non-lactating women, postpartum breast involution, and the epidemiology of breast cancer
6. Mutagenic activity in nipple aspirates of human breast fluid
7. Cytological abnormalities in nipple aspirates of breast fluid from women with severe constipation
8. Epidemiology of breast fluid secretion: Association with breast cancer risk factors and cerumen type
9. Epithelial dysplasia in nipple aspirates of breast fluid: Association with family history and other breast cancer risk factors
10. Nipple aspirate cytology for the study of breast cancer precursors
11. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid
12. Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens
13. Breast fluid cholesterol and cholesterol epoxides: Relationship to breast cancer risk factors and other characteristics
14. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk
15. Prognostic significance of atypical epithelial hyperplasia in nipple aspirates of breast fluid
16. Nipple aspirate fluids in adult nonlactating women-lactose content, cationic Na+, K+, Na+/K+ ratio, and coloration
17. Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease
18. Factors associated with obtaining nipple aspirate fluid: Analysis of 1428 women and literature review
19. The association of dietary fat with ability to obtain breast fluid by nipple aspiration
20. Association of abnormal nipple aspirate cytology and mammographic pattern and density
21. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
22. Screening for breast atypias using exfoliative cytology
23. Nonprostatic sources of prostate-specific antigen
24. Carcino-embryonic antigen in breast nipple aspirate fluid
25. Nipple aspirate fluid in epidemiologic studies of breast disease
26. Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease
27. Nipple aspirate fluid: A promising non-invasive method to identify cellular markers of breast cancer risk
28. Breast secretion in Finnish women: A metabolic epidemiologic study
29. Nipple aspirates of breast fluid and the epidemiology of breast disease
30. Cytologic evaluation of breast fluid in the detection of breast disease
31. Cerumen phenotype and epithelial dysplasia in nipple aspirates of breast fluid
32. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid
33. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration
34. Cancer. Introduction
35. Regression models and life-tables
36. Categorical data analysis using the SAS system
37. Epidemiology, prevention, and early detection of breast cancer
38. Gail model breast cancer risk components are poor predictors of risk perception and screening behavior
39. Models for early chemoprevention trials in breast cancer
40. Epidemiology, prevention, and early detection of breast cancer
41. Breast cancer screening
42. Breast cancer screening outcomes in women ages 40-49: Clinical experience with service screening using modern mammography
43. Predicting breast cancer: The search for a model
44. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model
45. Breast cancer susceptibility genes
46. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians
47. Inherited breast and ovarian cancer. What are the risks? What are the choices?
48. A prospective study of the development of breast cancer in 16 692 women with benign breast disease
49. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up
50. A prospective study of benign breast disease and the risk of breast cancer
51. Estrogen replacement therapy in women with a history of proliferative breast disease
52. Benign breast disease: Indicators of increased breast cancer risk
53. Indicators of increased breast cancer risk in humans
54. Prognostic significance of benign proliferative breast disease
55. Benign breast diseases, carcinoma in situ, and breast cancer risk
56. Chronic mastopathy and breast cancer. A follow-up study
57. Risk factors for breast cancer in women with proliferative breast disease
58. Anatomic indicators (histologic and cytologic) of increased breast cancer risk
59. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women
60. Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies
61. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size
62. ASO Distinguished Achievement Award Lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid